Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$810M |
| 2 |
Intuitive Surgical
ISRG
|
+$705M |
| 3 |
S&P Global
SPGI
|
+$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
FedEx
FDX
|
+$587M |
| 3 |
Monster Beverage
MNST
|
+$395M |
| 4 |
McDonald's
MCD
|
+$387M |
| 5 |
Booking.com
BKNG
|
+$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Cogent Biosciences
COGT
$1.78B
| $9.17M | 0.01% |
222,508
-11,319
| -5% | -$466K |
|
|
CEQP
477
DELISTED
Crestwood Equity Partners LP
CEQP
| $9.07M | 0.01% |
+246,757
| New | +$9.07M |
|
|
KA
478
DELISTED
Kineta, Inc. Common Stock
KA
| $8.89M | 0.01% |
26,358
+189
| +0.7% | +$63.8K |
|
479
Select Water Solutions
WTTR
$930M
| $8.75M | 0.01% |
738,572
-2,045
| -0.3% | -$24.2K |
|
|
ICD
480
DELISTED
Independence Contract Drilling, Inc.
ICD
| $8.69M | 0.01% |
87,932
-38
| -0% | -$3.76K |
|
481
Heritage Financial
HFWA
$842M
| $8.46M | 0.01% |
240,777
-2,383
| -1% | -$83.8K |
|
482
Neuronetics
STIM
$228M
| $8.22M | 0.01% |
256,532
-68,243
| -21% | -$2.19M |
|
|
FSTX
483
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $8.21M | 0.01% |
+170,333
| New | +$8.21M |
|
484
Wheaton Precious Metals
WPM
$47.9B
| $7.84M | 0.01% |
447,863
-32,790
| -7% | -$574K |
|
485
Teck Resources
TECK
$19.8B
| $7.72M | 0.01% |
+320,223
| New | +$7.72M |
|
|
ENLC
486
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $7.54M | 0.01% |
458,454
+20,784
| +5% | +$342K |
|
487
Warrior Met Coal
HCC
$3.08B
| $7.51M | 0.01% |
277,851
-121,359
| -30% | -$3.28M |
|
488
Hudbay
HBM
$5.33B
| $7.42M | 0.01% |
1,465,454
-137,468
| -9% | -$696K |
|
489
Heron Therapeutics
HRTX
$195M
| $7.19M | 0.01% |
227,051
+2,051
| +0.9% | +$64.9K |
|
490
Reliance Steel & Aluminium
RS
$15.4B
| $6.47M | 0.01% |
75,846
-53,400
| -41% | -$4.55M |
|
491
USA Compression Partners
USAC
$2.84B
| $6.35M | 0.01% |
384,594
+15,656
| +4% | +$258K |
|
492
Eastman Chemical
EMN
$7.47B
| $6.31M | 0.01% |
65,958
-8,331
| -11% | -$798K |
|
493
Quanterix
QTRX
$201M
| $6.3M | 0.01% |
294,314
-57,517
| -16% | -$1.23M |
|
494
Waste Connections
WCN
$45.3B
| $5.67M | 0.01% |
+71,047
| New | +$5.67M |
|
|
EQGP
495
DELISTED
EQGP Holdings, LP
EQGP
| $5.55M | 0.01% |
266,374
+11,410
| +4% | +$238K |
|
496
Antero Midstream
AM
$8.79B
| $5.54M | 0.01% |
327,155
+14,314
| +5% | +$242K |
|
497
iShares Russell 1000 Growth ETF
IWF
$119B
| $5.17M | ﹤0.01% |
33,149
-24,555
| -43% | -$3.83M |
|
498
Fate Therapeutics
FATE
$115M
| $4.89M | ﹤0.01% |
+300,000
| New | +$4.89M |
|
499
Walt Disney
DIS
$208B
| $4.41M | ﹤0.01% |
37,735
-619
| -2% | -$72.4K |
|
500
Mohawk Industries
MHK
$8.41B
| $3.91M | ﹤0.01% |
22,305
-214,409
| -91% | -$37.6M |
|